Neurointervention has seen significant advancements in recent decades with the adoption of myriad new technologies and techniques. Initially reliant on case reports and small case series, we now ...

At the moment, RevMed remains keenly focused on its mission to bring daraxonrasib to the masses and continue developing new medicines that target RAS. (Darren Incorvaia) This year’s meeting of the ...

Real-world data show that GLP-1 receptor agonists (GLP-1s) may reduce metastatic progression of certain obesity-related cancers, namely lung, breast, colorectal, and liver cancers. In addition, GLP-1 ...

Renovus Capital Partners Ranked #1 on HEC-Dow Jones Worldwide Performance Ranking of Small-Cap Private Equity Funds for Fourth Straight Year Renovus Capital Partners (“Renovus”), a Philadelphia-area ...

Although incomplete, the evidence is now sufficient to support “consideration” of adjunctive GLP-1 receptor agonists (RAs) in the treatment of patients with psoriasis and comorbid metabolic disorders, ...

Kestrel today announced that the first patient has been dosed in its phase 1 trial of KST-6051, an oral small molecule meant to inhibit multiple different kinds of KRAS mutations. (iStock / Getty ...

S15 - E19 Reunion Part 1 The reunion kicks off with some of the ladies seeking resolution while others remain doubtful following an emotionally charged season. A red-carpet sighting sparks questions ...

PARIS — RAS Luxury Skincare, the Indian farm-to-face brand, closed a 65 Crores, or $7.5 million, Series B funding round led by Dabur Ventures. Dabur Ventures is the venture arm of the largest ...

Clinical benefits regarding asthma stability were observed across all body mass index categories, including overweight, obese, and morbidly obese cohorts. Treatment with glucagon-like peptide-1 ...

About The Study: In this systematic review and meta-analysis, glucagon-like peptide-1 receptor agonists (GLP-1 RAs) produced greater weight loss among women than men; however, their efficacy was ...